Bill Garner

Dr Bill Garner MD MPH

Dr. William (Bill) Garner is a physician, investor and entrepreneur. Through EGB Ventures, Dr. Garner has made numerous public and private investments. Bill is currently Chairman of Race Oncology (ASX:RAC). Race Oncology is based on patents filed by EGB. Bill is Chairman of InMed Pharmaceuticals, Inc. (CSE:IN). Dr. Garner co-founded DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI).

Previously, Dr. Garner worked in medical affairs at Hoffmann LaRoche in oncology. Prior to Roche, Dr. Garner was a merchant banker in New York City. Dr. Garner has a Master of Public Health from Harvard and received his M.D. degree from New York Medical College. Dr. Garner did residency training in Anatomic Pathology at Columbia-Presbyterian and is currently a licensed physician in the State of New York. Among awards and honors, Dr. Garner was an AMA/Glaxo Wellcome Leadership Award recipient. Some of Dr. Garner’s research was funded by the American Federation for Aging Research.


Dr David Smithard BSc MBBS MD FRCP FRCSLT(Hon)

Chair of the UK Swallowing Disorders Research Group
Queen Elizabeth Hospital, Lewisham and Greenwich Trust , Greater London SE18 4QH
University of Greenwich, Greenwich, Greater London, SE9 2UG

David is a clinician researcher based in the South East of Greater London. He qualified form the London Hospital Medical College in 1986. He obtained his MD in Dysphagia following stroke from London University in 1997. He has been published 61 papers in peer reviewed journals as well as numerous presentations to Learned Societies (British Geriatric Society, European Society of Swallowing Disorders, UK Swallowing Research Group, Dysphagia Research Society, Society of Acute Medicine). He continues to conduct research into Dysphagia Rehabilitation focussing on sarcopenia, frailty and dysphagia and dysphagia post stroke. David is Chair of the UK Swallowing Research Group and has been a board member of the European Society for Swallowing Disorders and Hon Secretary of the British Association of Stroke Physicians. He has been awarded an honorary Fellowship by the Royal College of Speech and Language Therapists and is a Visiting Research Fellow at Greenwich University. David has delivered invited lectures (on dysphagia in older people and stroke) in many European countries (including Kazakhstan, Denmark, Switzerland, Germany and Italy). He is a member of various working groups looking into the management of dysphagia in Care Homes and in Acute settings.

Dr Ashley Benjamin

Awaiting Bio